SK281127B6 - Použitie inhibítora serínovej leukocytovej proteázy - Google Patents

Použitie inhibítora serínovej leukocytovej proteázy Download PDF

Info

Publication number: SK281127B6
Authority: SK; Slovakia
Prior art keywords: slpi; cells; hiv; mutein; infection
Prior art date: 1992-09-09

Application number

SK297-95A

Other languages

English (en)

Slovak (sk)

Other versions

SK29795A3 (en

Inventor

Stephen Eisenberg

Sharon M. Wahl

Robert C. Thompson

Original Assignee

Amgen Inc.

Dept. Of Health A. Human Services Office Of Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-09

Filing date

1993-09-09

Publication date

2000-12-11

1993-09-09 Application filed by Amgen Inc., Dept. Of Health A. Human Services Office Of Technology filed Critical Amgen Inc.

1997-02-05 Publication of SK29795A3 publication Critical patent/SK29795A3/sk

2000-12-11 Publication of SK281127B6 publication Critical patent/SK281127B6/sk

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SK297-95A 1992-09-09 1993-09-09 Použitie inhibítora serínovej leukocytovej proteázy SK281127B6 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94336992A	1992-09-09	1992-09-09
PCT/US1993/008486 WO1994006454A2 (en)	1992-09-09	1993-09-09	Inhibitiion of retrovirus infection

Publications (2)

Publication Number	Publication Date
SK29795A3 SK29795A3 (en)	1997-02-05
SK281127B6 true SK281127B6 (sk)	2000-12-11

Family

ID=25479533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK297-95A SK281127B6 (sk)	1992-09-09	1993-09-09	Použitie inhibítora serínovej leukocytovej proteázy

Country Status (23)

Country	Link
EP (1)	EP0666755B1 (de)
JP (2)	JP3517238B2 (de)
KR (1)	KR100273620B1 (de)
AT (1)	ATE238062T1 (de)
AU (1)	AU681350B2 (de)
CA (1)	CA2141951C (de)
CZ (1)	CZ286953B6 (de)
DE (1)	DE69332904T2 (de)
DK (1)	DK0666755T3 (de)
ES (1)	ES2197153T3 (de)
FI (1)	FI951078A0 (de)
HU (1)	HU218892B (de)
NO (1)	NO315546B1 (de)
NZ (1)	NZ256246A (de)
OA (1)	OA10133A (de)
PL (1)	PL307864A1 (de)
PT (1)	PT666755E (de)
RO (1)	RO116164B1 (de)
RU (1)	RU2126266C1 (de)
SG (1)	SG48115A1 (de)
SK (1)	SK281127B6 (de)
UA (1)	UA41338C2 (de)
WO (1)	WO1994006454A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5900401A (en) *	1994-03-23	1999-05-04	Tokyo Tanabe Company Limited	Remedy for respiratory-tract viral disease
WO1997003694A1 (fr) *	1995-07-24	1997-02-06	Tokyo Tanabe Company Limited	Remede contre les affections virales
US6270808B1 (en)	1995-11-13	2001-08-07	Gerard Voerman	Anti-viral isolates obtainable from leeches
US7276333B1 (en)	1999-05-13	2007-10-02	Japan Science And Technology Agency	Viral infection inhibitor targeting integrase N-terminal domain
DE10101792B4 (de) *	2001-01-17	2004-03-18	Vivotec Biomedical Technologies Gmbh	Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en)	2003-11-04	2012-10-16	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340877C (en) *	1987-12-28	2000-01-18	Takashi Sugiyama	Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) *	1988-11-28	1998-09-30	日本ケミカルリサーチ株式会社	エイズ治療および阻害剤
CA2007083A1 (en) *	1989-01-09	1990-07-09	Nobuhiko Katunuma	Pharmaceutical use of trypstatin
ES2097766T3 (es) *	1989-08-16	1997-04-16	Chiron Corp	Composiciones para la inhibicion de la formacion de hormonas proteicas y sus usos.
JPH05502868A (ja) *	1989-12-18	1993-05-20	トランスジーンソシエテアノニム	レトロウィルス感染症を治療又は予防する薬学的組成物
GR1001044B (el) *	1991-06-03	1993-04-28	Logothetou Rella Eleni	Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

1993
- 1993-09-09 SG SG1996007118A patent/SG48115A1/en unknown
- 1993-09-09 EP EP93921439A patent/EP0666755B1/de not_active Expired - Lifetime
- 1993-09-09 KR KR1019950700929A patent/KR100273620B1/ko not_active IP Right Cessation
- 1993-09-09 AT AT93921439T patent/ATE238062T1/de not_active IP Right Cessation
- 1993-09-09 JP JP50816294A patent/JP3517238B2/ja not_active Expired - Fee Related
- 1993-09-09 DE DE69332904T patent/DE69332904T2/de not_active Expired - Fee Related
- 1993-09-09 SK SK297-95A patent/SK281127B6/sk unknown
- 1993-09-09 HU HU9500682A patent/HU218892B/hu not_active IP Right Cessation
- 1993-09-09 UA UA95048317A patent/UA41338C2/uk unknown
- 1993-09-09 AU AU48530/93A patent/AU681350B2/en not_active Ceased
- 1993-09-09 CA CA002141951A patent/CA2141951C/en not_active Expired - Fee Related
- 1993-09-09 RU RU95109909A patent/RU2126266C1/ru not_active IP Right Cessation
- 1993-09-09 PT PT93921439T patent/PT666755E/pt unknown
- 1993-09-09 PL PL93307864A patent/PL307864A1/xx unknown
- 1993-09-09 CZ CZ1995559A patent/CZ286953B6/cs not_active IP Right Cessation
- 1993-09-09 WO PCT/US1993/008486 patent/WO1994006454A2/en active IP Right Grant
- 1993-09-09 NZ NZ256246A patent/NZ256246A/xx not_active IP Right Cessation
- 1993-09-09 DK DK93921439T patent/DK0666755T3/da active
- 1993-09-09 RO RO95-00493A patent/RO116164B1/ro unknown
- 1993-09-09 ES ES93921439T patent/ES2197153T3/es not_active Expired - Lifetime
1995
- 1995-03-08 FI FI951078A patent/FI951078A0/fi not_active Application Discontinuation
- 1995-03-08 NO NO19950897A patent/NO315546B1/no unknown
- 1995-03-09 OA OA60622A patent/OA10133A/en unknown
2003
- 2003-07-07 JP JP2003271629A patent/JP2004002455A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
RU2126266C1 (ru)	1999-02-20
AU4853093A (en)	1994-04-12
FI951078A (fi)	1995-03-08
NO315546B1 (no)	2003-09-22
WO1994006454A3 (en)	1994-08-18
ES2197153T3 (es)	2004-01-01
DK0666755T3 (da)	2003-08-04
PL307864A1 (en)	1995-06-26
WO1994006454A2 (en)	1994-03-31
EP0666755B1 (de)	2003-04-23
RU95109909A (ru)	1997-03-27
RO116164B1 (ro)	2000-11-30
HUT75126A (en)	1997-04-28
JP2004002455A (ja)	2004-01-08
EP0666755A1 (de)	1995-08-16
NO950897L (no)	1995-03-08
JP3517238B2 (ja)	2004-04-12
OA10133A (en)	1996-12-18
JPH08505042A (ja)	1996-06-04
HU218892B (hu)	2000-12-28
CZ55995A3 (en)	1996-01-17
CZ286953B6 (en)	2000-08-16
CA2141951A1 (en)	1994-03-31
ATE238062T1 (de)	2003-05-15
CA2141951C (en)	2007-04-24
UA41338C2 (uk)	2001-09-17
HU9500682D0 (en)	1995-04-28
NO950897D0 (no)	1995-03-08
PT666755E (pt)	2003-09-30
KR100273620B1 (ko)	2000-12-15
AU681350B2 (en)	1997-08-28
FI951078A0 (fi)	1995-03-08
DE69332904D1 (de)	2003-05-28
SG48115A1 (en)	1998-04-17
DE69332904T2 (de)	2003-11-06
SK29795A3 (en)	1997-02-05
NZ256246A (en)	1997-08-22
KR950703357A (ko)	1995-09-20

Publication	Publication Date	Title
ES2257752T3 (es)	2006-08-01	Uso de roxitromicina para la preparacion de un medicamento para mejorar la actividad biologica y antiviral de inhibidores de proteasa.
EP0675730B1 (de)	2001-03-14	Therapeutisches kombinationspräparat enthaltend interferon
AU723537B2 (en)	2000-08-31	The treatment of HIV and other viral infections using combinatorial therapy
WO1991018010A1 (en)	1991-11-28	Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
EP2377880A2 (de)	2011-10-19	Kombinationstherapie mit HIV-Fusions/Eintritts-Inhibitoren, die auf gp41 zielen
US5627035A (en)	1997-05-06	Peptides that block human immunodeficiency virus and methods of use thereof
US6017880A (en)	2000-01-25	Inhibition of retrovirus infection
SK281127B6 (sk)	2000-12-11	Použitie inhibítora serínovej leukocytovej proteázy
Richman	1991	Antiviral therapy of HIV infection
WO1994013314A1 (en)	1994-06-23	Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors
RU2290197C2 (ru)	2006-12-27	Фармацевтическое средство для лечения вич-инфекции, содержащая его композиция и способы его применения
US6869925B1 (en)	2005-03-22	Inhibition of retrovirus infection
JP2804979B2 (ja)	1998-09-30	エイズ治療および阻害剤
EP1075270B1 (de)	2005-06-15	Kurzes peptid zur behandlung neurodegenerativer erkrankungen
JP3770624B2 (ja)	2006-04-26	ウィルス感染・増殖抑制剤
KR100220531B1 (ko)	1999-10-01	인간의 면역 결핍 바이러스 감염을 차단시키는 펩티드 및 그것의 사용 방법
Pomerantz et al.	1987	Therapy of human immunodeficiency virus infections
AU3831889A (en)	1990-01-05	Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection
HU201679B (en)	1990-12-28	Process for producing synergetic pharmaceutical compositions against retrovirus contaminations
KR20030020561A (ko)	2003-03-10	헬리코박터 파일로리 유래의 신규한 항바이러스 펩타이드및 그의 용도